Dr. Lal PathLabs CEO Bharath Uppilliappan steps down
Uppilliappan joined Dr. Lal Pathlabs in 2016 as Chief Operating Officer and later became CEO
Uppilliappan joined Dr. Lal Pathlabs in 2016 as Chief Operating Officer and later became CEO
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
He is also inducted as a member of the management council and senior management personnel of the company
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Arco Lab now holds a 50% stake in Neviton
AMI to become part of Enpro’s Sealing Technologies Segment
Marks remarkable acceleration in innovation using AI technology
NEIAFMR to be developed as the national hub for folk medicine
Subscribe To Our Newsletter & Stay Updated